ZA200905067B - Nitric oxide releasing steroids - Google Patents

Nitric oxide releasing steroids

Info

Publication number
ZA200905067B
ZA200905067B ZA200905067A ZA200905067A ZA200905067B ZA 200905067 B ZA200905067 B ZA 200905067B ZA 200905067 A ZA200905067 A ZA 200905067A ZA 200905067 A ZA200905067 A ZA 200905067A ZA 200905067 B ZA200905067 B ZA 200905067B
Authority
ZA
South Africa
Prior art keywords
nitric oxide
oxide releasing
steroids
releasing steroids
nitric
Prior art date
Application number
ZA200905067A
Other languages
English (en)
Inventor
Francesca Benedini
Stefano Biondi
Ennio Ongini
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of ZA200905067B publication Critical patent/ZA200905067B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200905067A 2007-02-05 2009-07-20 Nitric oxide releasing steroids ZA200905067B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89937607P 2007-02-05 2007-02-05
US92945607P 2007-06-28 2007-06-28
PCT/EP2008/050938 WO2008095806A1 (fr) 2007-02-05 2008-01-28 Stéroïdes libérant de l'oxyde nitrique

Publications (1)

Publication Number Publication Date
ZA200905067B true ZA200905067B (en) 2010-04-28

Family

ID=39232800

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200905067A ZA200905067B (en) 2007-02-05 2009-07-20 Nitric oxide releasing steroids

Country Status (15)

Country Link
US (4) US8933062B2 (fr)
EP (3) EP2109618A1 (fr)
JP (1) JP5216782B2 (fr)
KR (1) KR20090107525A (fr)
CN (1) CN101652380A (fr)
AU (1) AU2008213046B2 (fr)
BR (1) BRPI0807078A2 (fr)
CA (3) CA2677442A1 (fr)
ES (1) ES2601102T3 (fr)
IL (1) IL199815A (fr)
MX (1) MX2009008334A (fr)
NZ (1) NZ579067A (fr)
RU (1) RU2442790C2 (fr)
WO (3) WO2008095806A1 (fr)
ZA (1) ZA200905067B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2796963A1 (fr) 2010-04-23 2011-10-27 Piramal Enterprises Limited Promedicaments d'agents therapeutiques liberant de l'oxyde nitrique
US8846723B2 (en) 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
WO2013053856A1 (fr) 2011-10-12 2013-04-18 Ascendis Pharma A/S Prévention et traitement d'états oculaires
PL2729220T3 (pl) * 2011-12-20 2016-05-31 Oriflame Res And Development Ltd Związki o aktywnościach przeciwstarzeniowych
JP6355636B2 (ja) 2012-10-11 2018-07-11 アセンディス ファーマ エー／エス 関節の疾患の診断、予防及び治療
WO2014111957A1 (fr) 2013-01-21 2014-07-24 Apparao Satyam Promédicaments d'agents thérapeutiques libérant de l'oxyde nitrique
RU2545416C1 (ru) * 2014-02-18 2015-03-27 Ксения Юрьевна Еременко Способ лечения возрастной макулярной дистрофии
CN103880907A (zh) * 2014-03-11 2014-06-25 天津金耀集团有限公司 丁酸氢化可的松半水合物
EP3538539A2 (fr) 2016-11-08 2019-09-18 Regeneron Pharmaceuticals, Inc. Stéroïdes et leurs conjugués protéiques
KR20200007905A (ko) 2017-05-18 2020-01-22 리제너론 파마슈티칼스 인코포레이티드 사이클로덱스트린 단백질 약물 접합체
WO2019217591A1 (fr) 2018-05-09 2019-11-14 Regeneron Pharmaceuticals, Inc. Anticorps anti-msr1 et leurs procédés d'utilisation
CN112638386A (zh) * 2018-08-31 2021-04-09 爱瑞制药公司 异喹啉-类固醇缀合物及其用途
WO2022135332A1 (fr) * 2020-12-21 2022-06-30 映恩生物制药（苏州）有限公司 Conjugué de stéroïdes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183252A (en) 1963-09-05 1965-05-11 Syntex Corp 16-nitratoalkyl-pregnanes
US3494941A (en) 1967-12-04 1970-02-10 American Home Prod Nitrate esters of 17beta-(hydroxyalkoxy)steroid 3-ols,3-ones and 3-amidinohydrazones
HU164115B (fr) 1971-05-07 1973-12-28
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
IT1311922B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (fr) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Prodrogues nitrées capable de libérer du monoxyde d'azote de manière controlée et sélective ainsi que leur utilisation pour la prévention et le traitement de maladies inflammatoires, ischémiques et proliferatives
CN101300265A (zh) * 2005-09-02 2008-11-05 尼科克斯公司 糖皮质激素硝酰氧基衍生物

Also Published As

Publication number Publication date
EP2109618A1 (fr) 2009-10-21
RU2009132993A (ru) 2011-03-20
RU2442790C2 (ru) 2012-02-20
US20100234334A1 (en) 2010-09-16
ES2601102T3 (es) 2017-02-14
NZ579067A (en) 2012-02-24
CA2677441C (fr) 2016-04-12
US20150105547A1 (en) 2015-04-16
EP2109617A1 (fr) 2009-10-21
EP2118120B1 (fr) 2016-10-05
CN101652380A (zh) 2010-02-17
CA2677290A1 (fr) 2008-08-14
JP2010517955A (ja) 2010-05-27
JP5216782B2 (ja) 2013-06-19
WO2008095809A1 (fr) 2008-08-14
WO2008095806A1 (fr) 2008-08-14
US8933062B2 (en) 2015-01-13
WO2008095808A1 (fr) 2008-08-14
KR20090107525A (ko) 2009-10-13
US20100093685A1 (en) 2010-04-15
US20100041633A1 (en) 2010-02-18
EP2118120A1 (fr) 2009-11-18
IL199815A (en) 2015-03-31
AU2008213046A1 (en) 2008-08-14
MX2009008334A (es) 2009-08-12
CA2677442A1 (fr) 2008-08-14
IL199815A0 (en) 2010-04-15
BRPI0807078A2 (pt) 2014-04-08
AU2008213046B2 (en) 2013-02-14
CA2677441A1 (fr) 2008-08-14

Similar Documents

Publication Publication Date Title
IL199815A0 (en) Nitric oxide releasing steroids
EP2445508A4 (fr) Thérapies par oxyde nitrique
EP2326382A4 (fr) Systèmes de production d oxyde nitrique
EP2501427A4 (fr) Système de distribution d'oxyde nitrique
EP2328592A4 (fr) Systèmes et dispositifs permettant la génération d oxyde nitrique
EP2155397A4 (fr) Dispositif de réduction de particule
EP2436999A4 (fr) Dispositif de conditionnement d'air
EP2376136A4 (fr) Procédés de diazéniumdiolation à l'état sec pour produire des dispositifs médicaux libérant de l'oxyde nitrique
EP2366450A4 (fr) Dispositif à microcanaux
HK1160835A1 (en) Nitric oxide donating prostamides
EP2320151A4 (fr) Dispositif de climatisation
EP2471799A4 (fr) Complexe de terre rare et ses utilisations
EP2236594A4 (fr) Agent d'élimination d'un biolfilm
EP2340543A4 (fr) Dispersion d oxyde métallique
GB2502460B (en) Composition and pyrotechnic device
EP2457092A4 (fr) Biomarqueur du cancer et son utilisation
EP2407476A4 (fr) Composé stéroïde
EP2517911A4 (fr) Dispositif pare-soleil
SG10201406420XA (en) Antiproliferative agent
EP2416078A4 (fr) Dispositif de climatisation
EP2602616A4 (fr) Elément détecteur d'oxyde nitrique
EP2471677A4 (fr) Dispositif pare-soleil
EP2062046A4 (fr) Détection d'oxyde nitrique
TWI351159B (en) Motor and guiding structure thereof
GB0908174D0 (en) Steroid containing composition and uses thereof